Journal of Experimental & Clinical Cancer ResearchCancer BiologyPeer-reviewed journal article
TGFb-ANGPT2-Tie2 axis in cancer-associated fibroblasts reprograms oral cancer cells to embryonic-like cell state with predictive significance of poor prognosis
Paromita Mitra, Uday Saha, Joshua Stephen KingslyiD, Priyanka Prasad, Subhashree JenaiD, Ankit Kumar PateliD, Harshavardhan BViD, Santosh Kumar Mondal, Sillarine Kurkalang, Sumitava Roy, Arnab GhoshiD, Shantanu Saha Roy, Jayasri Das SarmaiD, Nidhan K. BiswasiD, Moulinath AcharyaiD, Rajeev SharaniD, Pattatheyil AruniD, Mohit Kumar JollyiD, Arindam MaitraiD, Sandeep SinghiD
Abstract
Myofibroblastic cancer-associated fibroblasts (CAFs) in tumor stroma is identified as poor-prognostic indicator in oral cancer; however, biological mechanisms are largely unexplored. Here, we discovered the role of autocrine or exogenous transforming growth factor beta (TGF{beta}) in inducing Tunica Interna Endothelial cell kinase 2 (Tie2) -signaling through histone deacetylase-mediated downregulation of Tie2-antagonist, Angiopoietin-2 in CAFs, responsible for induction and maintenance of myofibroblastic differentiation. To understand the influence of CAF-specific Tie2-signaling on cancer cell properties, we performed CAF-Cancer cell co-culture and its single-cell RNA sequencing (scRNA-Seq). Distinct clustering of CAFs suggested their transcriptional heterogeneity, driven by TGF{beta}-Tie2 activation. Interestingly, CAF-specific Tie2-signaling was responsible to reprogram cancer cells, producing embryonic-like cell state with increased stemness and EMT signatures. Importantly, both the Tie2-specific gene expression signature as well as reprogrammed cancer cell specific gene expression modules were validated respectively in fibroblasts clusters and malignant cell clusters in two independent earlier reported scRNAseq studies of HNSCC tumors. Highlighting the translatability of our study, the gene expression signature derived from reprogrammed cancer cells showed significant association with poor prognosis in HNSCC patient of TCGA cohort. Pharmacological inhibition of Tie2-signaling in CAFs, significantly abrogated the tumor initiating ability of co-cultured oral cancer cell lines. Overall, combining our molecular and computational analysis, we may propose Tie2 as a novel factor responsible for CAF mediated cancer cell plasticity, associated with aggressive nature of oral cancer. TeaserTie2-signaling is activated in myofibroblasts which impacts the behaviour of malignant cells by inducing cancer cell plasticity to acquire stemness.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 5
- FWCI
- 2.04
- Field percentile
- top 12%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Distinct cancer-associated fibroblast states drive clinical outcomes in high-grade serous ovarian cancer and are regulated by TCF21
A. Hussain, V. Voisin, … L. Ailles·bioRxiv·May 10, 2019
- Pan-cancer single-cell analysis identifies a FOXF1/FOXF2-associated transitional CAF-like fibroblast state
Bayrta Mandzhieva, Ayushi Verma, … Woong‐Yang Park·bioRxiv·Jul 10, 2026
- Novel CAF-identifiers via transcriptomic analysis in oral cancer patients
N. Dwivedi, N. Shukla, … S. Dhar·bioRxiv·Jan 10, 2023
- In vitro effects of tensile strain on cancer-associated and matched normal fibroblasts derived from oral squamous cell carcinoma: an exploratory study
Nadine Wiesmann, Sebahat Kaya, … Peer Wolfgang Kämmerer·BMC CancerPeer-reviewed·Jul 21, 2026
- Cancer Associated Fibroblasts Mediate Cancer Progression and Remodel the Tumouroid Stroma
J. Pape, T. Magdeldin, … U. Cheema·bioRxiv·Nov 29, 2019
- Tumour-stroma signaling drives a reversible program with neural-like features in cancer-associated fibroblasts
Myriam Iliana Ibanez-Rios, Maëlle Batardière, … David J. H. F. Knapp·bioRxiv·Oct 9, 2026